HC
AXSM icon

Henshaw Capital’s Axsome Therapeutics AXSM Stock Holding History

Henshaw Capital’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,036
Closed -$612K – 172
2025
Q3 		$612K Sell
5,036
-1,835
-27% -$207K 0.02% 153
2025
Q2 		$717K Buy
6,871
+731
+12% +$77.4K 0.03% 189
2025
Q1 		$716K Buy
6,140
+659
+12% +$75.1K 0.03% 179
2024
Q4 		$464K Hold
5,481
– – 0.02% 233
2024
Q3 		$493K Buy
5,481
+453
+9% +$39.5K 0.02% 220
2024
Q2 		$405K Buy
5,028
+2,337
+87% +$173K 0.02% 202
2024
Q1 		$215K Buy
+2,691
New +$226K 0.01% 277

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return